Lentivirus-induced immune dysregulation

Veterinary Immunology and Immunopathology

Volumn 123, Issue 1-2, 2008, Pages 45-55

  Tompkins, Mary B ^a   Tompkins, Wayne A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

AIDS; FIV; Immune regulation; Immune suppression

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; L SELECTIN;

ANTIGENICITY; APOPTOSIS; B LYMPHOCYTE; CAT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DOWN REGULATION; FELINE IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LENTIVIRINAE; NONHUMAN; PATHOGENESIS; PHENOTYPE; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; APOPTOSIS; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNITY, CELLULAR; IMMUNODEFICIENCY VIRUS, FELINE;

FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 43049168298     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.01.011     Document Type: Review

References (85)

1. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., and Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78 (2004) 2454-2459
2. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., and Cooper M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64 (1990) 5652-5655
3. Andersson J., Boasso A., Nilsson J., Zhang R., Shire N.J., Lindback S., Shearer G.M., and Chougnet C.A. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174 (2005) 3143-3147
4. Ascher M., and Sheppard H. AIDS as immune system activation. II. The panergic imnesia hypothesis. J. Acquir. Immune. Defic. Syndr. 3 (1990) 177-191
5. Avery P.R., and Hoover E.A. Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection. J. Virol. 78 (2004) 4011-4019
6. Barlough J.E., Ackley C.D., George J.W., Levy N., Acevedo R., Moore P.F., Rideout B.A., Cooper M.D., and Pedersen N.C. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquir. Immune. Defic. Syndr. 4 (1991) 219-227
7. Beatty J., Willett B., Gault E., and Jarrett O. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70 (1996) 6199-6206
8. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
9. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., and Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8 (1995) 87-112
10. Bluestone J. Is CTLA-4 a master switch for peripheral T cell tolerance?. J. Immunol. 158 (1997) 1989-1993
11. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3 (2003) 253-257
12. Bucci J., English R., Jordan H., Childers T., Tompkins M., and Tompkins W. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 177 (1998) 18-25
13. Bucci J., Gebhard D., Childers T., English R., Tompkins M., and Tompkins W. The CD8+ phenotype mediating antiviral activity in FIV-infected cats is characterized by reduced surface expression of the CD8 beta chain. J. Infect. Dis. 178 (1998) 968-977
14. Bull M., Vahlenkamp T., Dow J., Collisson E., Winslow B., Phadke A., Tompkins M., and Tompkins W. Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL-2 and anti-B7.1 antibodies. Vet. Immunol. Immunopathol. 99 (2004) 25-37
15. Burkhard M.J., Mathiason C.K., Bowdre T., and Hoover E.A. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection. AIDS Res. Hum. Retrovir. 17 (2001) 1767-1778
16. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
17. Choi I.S., Hokanson R., and Collisson E.W. Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication. J. Virol. 74 (2000) 676-683
18. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14 (1993) 107-111
19. Clerici M., Stocks N., Zajac R., Boswell R., Lucey D., Via C., and Shearer G. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositve patients. J. Clin. Invest. 84 (1989) 1892-1899
20. Davidson M.G., Lappin M.R., English R.V., and Tompkins M.B. A feline model of ocular toxoplasmosis. Investig. Ophthalmol. Vis. Sci. 34 (1993) 3653-3660
21. Davidson M.G., Rottman J., English R.V., Lappin M.R., and Tompkins M.B. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am. J. Pathol. 143 (1993) 1486-1497
22. Dean G.A., and Pedersen N.C. Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection. J. Virol. 72 (1998) 9436-9440
23. Dean G.A., Bernales J.A., and Pedersen N.C. Effect of feline immunodeficiency virus on cytokine response to Listeria monocytogenes in vivo. Vet. Immunol. Immunopathol. 65 (1998) 125-138
24. Dean G.A., LaVoy A., Yearley J., and Stanton C. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J. Infect. Dis. 193 (2006) 1520-1527
25. Egberink H.F., Keldermans C.E., Koolen M.J., and Horzinek M.C. Humoral immune response to feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections. Am. J. Vet. Res. 53 (1992) 1133-1138
26. English R.V., Nelson P., Johnson C.M., Nasisse M., Tompkins W.A., and Tompkins M.B. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170 (1994) 543-552
27. Estes J.D., Li Q., Reynolds M.R., Wietgrefe S., Duan L., Schacker T., Picker L.J., Watkins D.I., Lifson J.D., Reilly C., Carlis J., and Haase A.T. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193 (2006) 703-712
28. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172 (2004) 5149-5153
29. Finkel T., Tudor-Williams G., Banda N., Cotton M., Curiel T., Monks C., Baba T., Ruprecht R., and Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1 (1995) 129-134 (see comments)
30. Flynn J.N., Cannon C.A., Lawrence C.E., and Jarrett O. Polyclonal B-cell activation in cats infected with feline immunodeficiency virus. Immunology 81 (1994) 626-630
31. Flynn J.N., Dunham S., Mueller A., Cannon C., and Jarrett O. Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 85 (2002) 159-170
32. Folzenlogen D., Hofer M., Leung D., Freed J., and Newell M. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin. Immunol. Immunopathol. 83 (1997) 199-204 (see comments)
33. Gebhard D., Dow J., Childers T., Alvelo J., Tompkins M., and Tompkins W. Progressive expansion of an l-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 180 (1999) 1503-1513
34. Graziosi C., Pantaleo G., Gantt K.R., Fortin J.P., Demarest J.F., Cohen O.J., Sekaly R.P., and Fauci A.S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265 (1994) 248-252
35. Guiot A., Rigal D., Bernaud J., Aeberle C., Soulier M., and Chappuis G. Demonstration of cell death process by apoptosis in cat lymphocytes infected by FIV (feline immunodeficiency virus). C.R. Acad. Sci. III 316 (1993) 1297-1304
36. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., Hamann D., Prins M., and Miedema F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17 (2003) 1881-1888
37. Hohdatsu T., Pu R., Torres B.A., Trujillo S., Gardner M.B., and Yamamoto J.K. Passive antibody protection of cats against feline immunodeficiency virus infection. J. Virol. 67 (1993) 2344-2348
38. Hohdatsu T., Okubo M., and Koyama H. Feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus activity mediated by a soluble factor(s). J. Gen. Virol. 79 Pt 11 (1998) 2729-2735
39. Hohdatsu T., Yamazaki A., Yamada M., Kusuhara H., Kaneshima T., and Koyama H. Ability of CD8(+) T cell anti-feline immunodeficiency virus activity correlated with peripheral CD4(+) T cell counts and plasma viremia. Microbiol. Immunol. 47 (2003) 765-773
40. Hori S., Carvalho T.L., and Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32 (2002) 1282-1291
41. Iwashiro M., Messer R.J., Peterson K.E., Stromnes I.M., Sugie T., and Hasenkrug K.J. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9226-9230
42. Joshi A., Vahlenkamp T.W., Garg H., Tompkins W.A., and Tompkins M.B. Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation. Virology 321 (2004) 307-322
43. Kinter A.L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., Planta M., McGlaughlin M., Jackson R., Ziegler S.F., and Fauci A.S. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200 (2004) 331-343
44. Kornfeld C., Ploquin M.J., Pandrea I., Faye A., Onanga R., Apetrei C., Poaty-Mavoungou V., Rouquet P., Estaquier J., Mortara L., Desoutter J.F., Butor C., Le Grand R., Roques P., Simon F., Barre-Sinoussi F., Diop O.M., and Muller-Trutwin M.C. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115 (2005) 1082-1091
45. Lawrence C.E., Callanan J.J., Willett B.J., and Jarrett O. Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology 85 (1995) 568-574
46. Leng Q., Bentwich Z., Magen E., Kalinkovich A., and Borkow G. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16 (2002) 519-529
47. Levy J., Mackewicz C., and Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ cells. Immunol. Today 17 (1996) 217-224
48. Levy J., Ritchey J., Rottman J., Davidson M., Liang Y., Jordan H., Tompkins W., and Tompkins M. Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii. J. Infect. Dis. 178 (1998) 503-511
49. Levy J.K., Liang Y., Ritchey J.W., Davidson M.G., Tompkins W.A., and Tompkins M.B. Failure of FIV-infected cats to control Toxoplasma gondii correlates with reduced IL2, IL6, and IL12 and elevated IL10 expression by lymph node T cells. Vet. Immunol. Immunopathol. 98 (2004) 101-111
50. Lombardi S., Garzelli C., La Rosa C., Zaccaro L., Specter S., Malvaldi G., Tozzini F., Esposito F., and Bendinelli M. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 67 (1993) 4742-4749
51. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2 (2001) 816-822
52. Meroni L., Trabattoni D., Balotta C., Riva C., Clerici M., and Galli M. Evidence for type 2 cytokine production and lymphocyte activiation in early phases of HIV-1 infection. AIDS 10 (1996) 23-30
53. Miedema F. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic. Rev. 3 (1992) 173-193
54. Muro-Cacho C., Pantaleo G., and Fauci A. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154 (1995) 5555-5566
55. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 (2001) 629-644
56. Piccirillo C.A., and Thornton A.M. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol. 25 (2004) 374-380
57. Ranheim E., and Kipps T. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 37 (1994) 1637-1646
58. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192 (2000) 295-302
59. Ritchey J.W., Levy J.K., Bliss S.K., Tompkins W.A., and Tompkins M.B. Constitutive expression of types 1 and 2 cytokines by alveolar macrophages from feline immunodeficiency virus-infected cats. Vet. Immunol. Immunopathol. 79 (2001) 83-100
60. Rushbrook S.M., Ward S.M., Unitt E., Vowler S.L., Lucas M., Klenerman P., and Alexander G.J. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79 (2005) 7852-7859
61. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
62. Sarli G., Della Salda L., Zaccaro L., Bendinelli M., Piedimonte G., and Marcato P. Apoptotic fraction in lymphoid tissue of FIV-infected SPF cats. Vet. Immunol. Immunopathol. 64 (1998) 33-44
63. Shevach E.M., McHugh R.S., Piccirillo C.A., and Thornton A.M. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182 (2001) 58-67
64. Siebelink K.H., Rimmelzwaan G.F., Bosch M.L., Meloen R.H., and Osterhaus A.D. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J. Virol. 67 (1993) 2202-2208
65. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A., Stepankova R., Tlaskalova H., and Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182 (2001) 190-200
66. Song W., Collisson E., Billingsley P., and Brown W. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66 (1992) 5409-5417
67. Song W., Collisson E., Li J., Wolf A., Elder J., Grant C., and Brown W. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. Virology 209 (1995) 390-399
68. Sousa A.E., Carneiro J., Meier-Schellersheim M., Grossman Z., and Victorino R.M. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
69. Than S., Hu R., Oyaizu N., Romano J., Wang X., Sheikh S., and Pahwa S. Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. J. Infect. Dis. 175 (1997) 47-56
70. Thornton A.M., and Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
71. Tompkins M.B., Nelson P.D., English R.V., and Novotney C. Early events in the immunopathogenesis of feline retrovirus infections. J. Am. Vet. Med. Assoc. 199 (1991) 1311-1315
72. Tompkins M.B., Bull M.E., Dow J.L., Ball J.M., Collisson E.W., Winslow B.J., Phadke A.P., Vahlenkamp T.W., and Tompkins W.A. Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis. J. Infect. Dis. 185 (2002) 1077-1093
73. Torten M., Franchini M., Barlough J.E., George J.W., Mozes E., Lutz H., and Pedersen N.C. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J. Virol. 65 (1991) 2225-2230
74. Tozzini F., Matteucci D., Bandecchi P., Baldinotti F., Siebelink K., Osterhaus A., and Bendinelli M. Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31 (1993) 1626-1629
75. Trabattoni D., Saresella M., Biasin M., Boasso A., Piacentini L., Ferrante P., Dong H., Maserati R., Shearer G.M., Chen L., and Clerici M. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101 (2003) 2514-2520
76. Vahlenkamp T., Bull M., Dow J., Collisson E., Winslow B., Phadke A., Tompkins W., and Tompkins M. B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: A model for feline immunodeficiency-induced T cell depletion. Vet. Immunol. Immunopathol. 98 (2004) 203-214
77. Vahlenkamp T., Tompkins M., and Tompkins W. Feline immunodeficiency virus (FIV) infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory (Treg) cells. J. Immunol. 172 (2004) 4752-4761
78. Vahlenkamp T.W., Tompkins M.B., and Tompkins W.A. FIV as a model of AIDS pathogenesis studies. In: Friedman H., Specter S., and Bendinelli M. (Eds). In Vivo Models of HIV Disease and Control (2006), Springer, New York 239-273
79. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., and Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112 (2003) 1437-1443
80. Weiss L., Donkova-Petrini V., Caccavelli L., Balbo M., Carbonneil C., and Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104 (2004) 3249-3256
81. Willett B.J., Hosie M.J., Callanan J.J., Neil J.C., and Jarrett O. Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology 78 (1993) 1-6
82. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., and Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177 (2006) 739-747
83. Yamamoto J.K., Sparger E., Ho E.W., Andersen P.R., O'Connor T.P., Mandell C.P., Lowenstine L., Munn R., and Pedersen N.C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49 (1988) 1246-1258
84. Yamamoto J.K., Okuda T., Ackley C.D., Louie H., Pembroke E., Zochlinski H., Munn R.J., and Gardner M.B. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retrovir. 7 (1991) 911-922
85. Yang J., English R., Ritchey J., Davidson M., Wasmoen T., Levy J., Gebhard D., Tompkins M., and Tompkins W. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J. Virol. 70 (1996) 3011-3017